Screener
Agios Pharmaceuticals AGIO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's free cash flow?
- Agios Pharmaceuticals (AGIO) reported free cash flow of -$58.52M in Q2 2026.
- How has Agios Pharmaceuticals's free cash flow changed year-over-year?
- Agios Pharmaceuticals's free cash flow increased by 25.0% year-over-year, from -$78M to -$58.52M.
- What is the long-term trend for Agios Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Agios Pharmaceuticals's free cash flow has grown at a -2.2% compound annual growth rate (CAGR), from -$413.06M to -$377.29M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Agios Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude